Broadcasting
Compare Stocks
2 / 10Stock Comparison
CURI vs NFLX
Revenue, margins, valuation, and 5-year total return — side by side.
Entertainment
CURI vs NFLX — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Broadcasting | Entertainment |
| Market Cap | $184M | $374.00B |
| Revenue (TTM) | $72M | $45.18B |
| Net Income (TTM) | $-6M | $10.98B |
| Gross Margin | 56.6% | 48.5% |
| Operating Margin | -10.2% | 29.5% |
| Forward P/E | 89.7x | 24.8x |
| Total Debt | $12M | $14.46B |
| Cash & Equiv. | $18M | $9.03B |
CURI vs NFLX — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| CuriosityStream Inc. (CURI) | 100 | 32.1 | -67.9% |
| Netflix, Inc. (NFLX) | 100 | 210.3 | +110.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CURI vs NFLX
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CURI is the clearest fit if your priority is growth exposure and sleep-well-at-night.
- Rev growth 40.1%, EPS growth 54.2%, 3Y rev CAGR -2.8%
- Lower volatility, beta 1.44, Low D/E 30.0%, current ratio 1.23x
- 40.1% revenue growth vs NFLX's 15.9%
NFLX carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- beta 0.39
- 8.8% 10Y total return vs CURI's -63.2%
- Beta 0.39, current ratio 1.19x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 40.1% revenue growth vs NFLX's 15.9% | |
| Value | Lower P/E (24.8x vs 89.7x) | |
| Quality / Margins | 24.3% margin vs CURI's -9.0% | |
| Stability / Safety | Beta 0.39 vs CURI's 1.44 | |
| Dividends | 12.2% yield; 2-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | -23.1% vs NFLX's -23.6% | |
| Efficiency (ROA) | 19.8% ROA vs CURI's -8.2%, ROIC 29.8% vs -12.2% |
CURI vs NFLX — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CURI vs NFLX — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
NFLX leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
NFLX is the larger business by revenue, generating $45.2B annually — 630.5x CURI's $72M. NFLX is the more profitable business, keeping 24.3% of every revenue dollar as net income compared to CURI's -9.0%. On growth, CURI holds the edge at +35.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $72M | $45.2B |
| EBITDAEarnings before interest/tax | $14M | $30.1B |
| Net IncomeAfter-tax profit | -$6M | $11.0B |
| Free Cash FlowCash after capex | $13M | $9.5B |
| Gross MarginGross profit ÷ Revenue | +56.6% | +48.5% |
| Operating MarginEBIT ÷ Revenue | -10.2% | +29.5% |
| Net MarginNet income ÷ Revenue | -9.0% | +24.3% |
| FCF MarginFCF ÷ Revenue | +18.1% | +20.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | +35.8% | +17.6% |
| EPS Growth (YoY)Latest quarter vs prior year | -31.2% | +31.1% |
Valuation Metrics
CURI leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
On an enterprise value basis, NFLX's 12.6x EV/EBITDA is more attractive than CURI's 24.2x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $184M | $374.0B |
| Enterprise ValueMkt cap + debt − cash | $179M | $379.4B |
| Trailing P/EPrice ÷ TTM EPS | -28.55x | 34.89x |
| Forward P/EPrice ÷ next-FY EPS est. | 89.71x | 24.80x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.06x |
| EV / EBITDAEnterprise value multiple | 24.22x | 12.61x |
| Price / SalesMarket cap ÷ Revenue | 2.57x | 8.28x |
| Price / BookPrice ÷ Book value/share | 4.36x | 14.32x |
| Price / FCFMarket cap ÷ FCF | 14.24x | 39.53x |
Profitability & Efficiency
NFLX leads this category, winning 5 of 8 comparable metrics.
Profitability & Efficiency
NFLX delivers a 41.3% return on equity — every $100 of shareholder capital generates $41 in annual profit, vs $-13 for CURI. CURI carries lower financial leverage with a 0.30x debt-to-equity ratio, signaling a more conservative balance sheet compared to NFLX's 0.54x. On the Piotroski fundamental quality scale (0–9), NFLX scores 7/9 vs CURI's 5/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -13.1% | +41.3% |
| ROA (TTM)Return on assets | -8.2% | +19.8% |
| ROICReturn on invested capital | -12.2% | +29.8% |
| ROCEReturn on capital employed | -13.6% | +30.5% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 7 |
| Debt / EquityFinancial leverage | 0.30x | 0.54x |
| Net DebtTotal debt minus cash | -$6M | $5.4B |
| Cash & Equiv.Liquid assets | $18M | $9.0B |
| Total DebtShort + long-term debt | $12M | $14.5B |
| Interest CoverageEBIT ÷ Interest expense | — | 17.33x |
Total Returns (Dividends Reinvested)
Evenly matched — CURI and NFLX each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in NFLX five years ago would be worth $17,519 today (with dividends reinvested), compared to $2,978 for CURI. Over the past 12 months, CURI leads with a -23.1% total return vs NFLX's -23.6%. The 3-year compound annual growth rate (CAGR) favors CURI at 54.7% vs NFLX's 38.6% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -14.4% | -3.0% |
| 1-Year ReturnPast 12 months | -23.1% | -23.6% |
| 3-Year ReturnCumulative with dividends | +270.5% | +166.5% |
| 5-Year ReturnCumulative with dividends | -70.2% | +75.2% |
| 10-Year ReturnCumulative with dividends | -63.2% | +875.3% |
| CAGR (3Y)Annualised 3-year return | +54.7% | +38.6% |
Risk & Volatility
NFLX leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
NFLX is the less volatile stock with a 0.39 beta — it tends to amplify market swings less than CURI's 1.44 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NFLX currently trades 65.8% from its 52-week high vs CURI's 43.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.44x | 0.39x |
| 52-Week HighHighest price in past year | $7.15 | $134.12 |
| 52-Week LowLowest price in past year | $2.81 | $75.01 |
| % of 52W HighCurrent price vs 52-week peak | +43.9% | +65.8% |
| RSI (14)Momentum oscillator 0–100 | 43.0 | 35.3 |
| Avg Volume (50D)Average daily shares traded | 349K | 44.0M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates CURI as "Buy" and NFLX as "Buy". Consensus price targets imply 31.8% upside for NFLX (target: $116) vs 16.9% for CURI (target: $4). CURI is the only dividend payer here at 12.16% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $3.67 | $116.29 |
| # AnalystsCovering analysts | 9 | 99 |
| Dividend YieldAnnual dividend ÷ price | +12.2% | — |
| Dividend StreakConsecutive years of raises | 2 | — |
| Dividend / ShareAnnual DPS | $0.38 | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +2.4% |
NFLX leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). CURI leads in 1 (Valuation Metrics). 1 tied.
CURI vs NFLX: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is CURI or NFLX a better buy right now?
For growth investors, CuriosityStream Inc.
(CURI) is the stronger pick with 40. 1% revenue growth year-over-year, versus 15. 9% for Netflix, Inc. (NFLX). Netflix, Inc. (NFLX) offers the better valuation at 34. 9x trailing P/E (24. 8x forward), making it the more compelling value choice. Analysts rate CuriosityStream Inc. (CURI) a "Buy" — based on 9 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CURI or NFLX?
On forward P/E, Netflix, Inc.
is actually cheaper at 24. 8x.
03Which is the better long-term investment — CURI or NFLX?
Over the past 5 years, Netflix, Inc.
(NFLX) delivered a total return of +75. 2%, compared to -70. 2% for CuriosityStream Inc. (CURI). Over 10 years, the gap is even starker: NFLX returned +875. 3% versus CURI's -63. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CURI or NFLX?
By beta (market sensitivity over 5 years), Netflix, Inc.
(NFLX) is the lower-risk stock at 0. 39β versus CuriosityStream Inc. 's 1. 44β — meaning CURI is approximately 269% more volatile than NFLX relative to the S&P 500. On balance sheet safety, CuriosityStream Inc. (CURI) carries a lower debt/equity ratio of 30% versus 54% for Netflix, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — CURI or NFLX?
By revenue growth (latest reported year), CuriosityStream Inc.
(CURI) is pulling ahead at 40. 1% versus 15. 9% for Netflix, Inc. (NFLX). On earnings-per-share growth, the picture is similar: CuriosityStream Inc. grew EPS 54. 2% year-over-year, compared to 27. 6% for Netflix, Inc.. Over a 3-year CAGR, NFLX leads at 12. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CURI or NFLX?
Netflix, Inc.
(NFLX) is the more profitable company, earning 24. 3% net margin versus -9. 0% for CuriosityStream Inc. — meaning it keeps 24. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NFLX leads at 29. 5% versus -10. 2% for CURI. At the gross margin level — before operating expenses — CURI leads at 56. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CURI or NFLX more undervalued right now?
On forward earnings alone, Netflix, Inc.
(NFLX) trades at 24. 8x forward P/E versus 89. 7x for CuriosityStream Inc. — 64. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NFLX: 31. 8% to $116. 29.
08Which pays a better dividend — CURI or NFLX?
In this comparison, CURI (12.
2% yield) pays a dividend. NFLX does not pay a meaningful dividend and should not be held primarily for income.
09Is CURI or NFLX better for a retirement portfolio?
For long-horizon retirement investors, Netflix, Inc.
(NFLX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 39), +875. 3% 10Y return). Both have compounded well over 10 years (NFLX: +875. 3%, CURI: -63. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CURI and NFLX?
Both stocks operate in the Communication Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
CURI pays a dividend while NFLX does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
- Sector: Communication Services
- Market Cap > $100B
- Revenue Growth > 17%
- Gross Margin > 33%
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.